trial

Molecular Variants Associated With Schizophrenia: Differential Analysis of Monozygotic Twins With Variable Phenotypic 22q11

NCTId NCT04141540
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 2 (actual)
Sponsored by Hôpital le Vinatier
Primary completion 2020-11-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
2 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2020-03-27
Primary completion
2020-11-30
Eligibility
MALE · 18 Years · 45 Years

Interventions & indications

Drugs
Molecular analyses

Sponsors

Hôpital le VinatierLead Sponsor

Investigators

1
DEMILY CAROLINE, MD PH.DPrincipal Investigator

Sites

1 total
Lyon, France

Facts & assertions

4 sourced
Enrollment
2
Phase
NA
Primary Completion Date
2020-11-30
Status
COMPLETED
relationships
The graph out of here
drug
Molecular analyses
drug
lead_sponsor
Hôpital le Vinatier
company
indication
Di George Syndrome
indication
DiGeorge Syndrome
indication
investigator
DEMILY CAROLINE, MD PH.D
person